Ethinyl Estradiol + Dienogest
Abstract
No abstract
References
1. Goldzieher JW. Pharmacokinetics and metabolism of ethinyl estrogens. In: Goldzieher JW, Fotherby K, editors. Pharmacology of the contraceptive steroids. New York: Raven
Press Ltd, 1994: 127-52
2. Oettel M, Bervoas-Martin S, Elger W, et al. A 19-norprogestin without a 17alpha-ethinyl group. I: dienogest from a pharmacokinetic point of view. Drugs Today 1995;31:499-516
3. Oettel M, Carol W, Elger W, et al. A 19-norprogestin without a 17alpha-ethinyl group. II: dienogest from a phar-macodynamic point of view. Drugs Today 1995; 31: 517-36
4. Moore C, Feichtinger W, Klinger G, et al. Clinical findings with the dienogest-containing oral contraceptive Valette. Drugs Today 1999; 35 Suppl. C: 53-68
5. Moore C, Luderschmidt C, Moltz L, et al. Antiandrogenic properties of the dienogest-containing oral contraceptive Valette. Drugs Today 1999; 35 Suppl. C: 69-78
6. Spona J, Feichtinger W, Kindermann C, et al. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system. Contraception 1997 Aug; 56 (2): 67-75
7. S. Golbs et al. Clinical Findings with the Oral Contraceptive Combination Ethinylestradiol/Dienogest in Poland. Methods Find ExpClinPharmacol 2002, 24(9): 585-592
8. S. Golbs et al. Clinical Findings with the Oral Contraceptive Combination Ethinylestradiol/Dienogest in the Czech Republic. Methods Find ExpClinPharmacol 2002,24(10):689-696
9. Davies J et al. Heavy menstrual bleeding: An update on management. Thrombosis Research 151 suppl 1 (2017) S71-77.
Press Ltd, 1994: 127-52
2. Oettel M, Bervoas-Martin S, Elger W, et al. A 19-norprogestin without a 17alpha-ethinyl group. I: dienogest from a pharmacokinetic point of view. Drugs Today 1995;31:499-516
3. Oettel M, Carol W, Elger W, et al. A 19-norprogestin without a 17alpha-ethinyl group. II: dienogest from a phar-macodynamic point of view. Drugs Today 1995; 31: 517-36
4. Moore C, Feichtinger W, Klinger G, et al. Clinical findings with the dienogest-containing oral contraceptive Valette. Drugs Today 1999; 35 Suppl. C: 53-68
5. Moore C, Luderschmidt C, Moltz L, et al. Antiandrogenic properties of the dienogest-containing oral contraceptive Valette. Drugs Today 1999; 35 Suppl. C: 69-78
6. Spona J, Feichtinger W, Kindermann C, et al. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system. Contraception 1997 Aug; 56 (2): 67-75
7. S. Golbs et al. Clinical Findings with the Oral Contraceptive Combination Ethinylestradiol/Dienogest in Poland. Methods Find ExpClinPharmacol 2002, 24(9): 585-592
8. S. Golbs et al. Clinical Findings with the Oral Contraceptive Combination Ethinylestradiol/Dienogest in the Czech Republic. Methods Find ExpClinPharmacol 2002,24(10):689-696
9. Davies J et al. Heavy menstrual bleeding: An update on management. Thrombosis Research 151 suppl 1 (2017) S71-77.
Published
2019-11-26
How to Cite
Dr. Devendra Khandke,Dr P C Mahapatra , Dr D Patil. (2019). Ethinyl Estradiol + Dienogest. The Indian Practitioner, 72(11), 29-31. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/873
Section
Drug Profile
